Aqr Arbitrage LLC Precigen, Inc. Transaction History

Aqr Arbitrage LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.74 - $10.95 $155,599 - $252,791	-23,086 Reduced 49.18%	23,855 $164,000
Q3 2020 Nov 16, 2020	SELL	$3.5 - $6.2 $211,568 - $374,777	-60,448 Reduced 56.29%	46,941 $164,000
Q2 2020 Aug 17, 2020	SELL	$2.16 - $5.46 $191,041 - $482,909	-88,445 Reduced 45.16%	107,389 $536,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $285,917 - $1.41 Million	195,834 New	195,834 $666,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Aqr Arbitrage LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Arbitrage LLC with notifications on news.